In 2023, Servier formed an international collaborative group, the Patient Advisory Council (PAC), to involve patients in the entire medicine life cycle, with initial focus on diabetes and expansion into cardiovascular diseases. The PAC, comprising representatives from 15 countries, co-authored an article highlighting the importance of treatment adherence. Servier is addressing therapeutic adherence challenges, particularly in managing silent cardiovascular and metabolic diseases, through innovations like Single Pill Combinations and “Beyond the Pill” programs. Committed to patient engagement, Servier aims to ensure that all therapeutic areas and clinical trials incorporate patient insights. Their efforts culminate in initiatives like World Adherence Day on March 27.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://servier.com/en/newsroom/patient-organizations-treatment-adherence/
